glp 1 severe constipation Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus Severe constipation is never OK
Description
EMBO Mol Med
Crajoinas RO, Oricchio FT, Pessoa TD, Pacheco BP, Lessa LM, Malnic G, et al

Br J Pharmacol (2012) 166(5):158699
Importantly, these effects were not accompanied by reductions in locomotor activity or food reinforcement, suggesting specificity for opioid-directed behavior

Why It Matters GLP-1 receptor agonists are everywhere

This article is exclusive to STAT+ subscribers Unlock this article plus daily intelligence on Capitol Hill and the life sciences industry by subscribing to STAT+